NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

JNJ

Johnson & Johnson

May 16 • 10:29AM ET

151.02

Dollar change +1.41
Percentage change 0.94	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IWD DIA

Scroll to Statements

Index	DJIA, S&P 500	P/E	16.79	EPS (ttm)	9.00	Insider Own	0.14%	Shs Outstand	2.41B	Perf Week	-2.07%
Market Cap	363.37B	Forward P/E	13.60	EPS next Y	11.10	Insider Trans	-0.57%	Shs Float	2.41B	Perf Month	-1.88%
Income	21.81B	PEG	2.85	EPS next Q	2.68	Inst Own	73.29%	Short Float	0.82%	Perf Quarter	-3.29%
Sales	89.33B	P/S	4.07	EPS this Y	6.33%	Inst Trans	0.57%	Short Ratio	2.03	Perf Half Y	-1.06%
Book/sh	32.47	P/B	4.65	EPS next Y	4.61%	ROA	11.93%	Short Interest	19.68M	Perf Year	-0.24%
Cash/sh	16.12	P/C	9.37	EPS next 5Y	5.90%	ROE	29.45%	52W Range	140.68 - 169.99	Perf YTD	4.43%
Dividend Est.	5.14 (3.40%)	P/FCF	17.84	EPS past 5Y	0.55%	ROI	18.73%	52W High	-11.16%	Beta	0.39
Dividend TTM	4.96 (3.28%)	Quick Ratio	1.03	Sales past 5Y	2.03%	Gross Margin	68.24%	52W Low	7.35%	ATR (14)	3.31
Dividend Ex-Date	May 27, 2025	Current Ratio	1.26	EPS Y/Y TTM	29.21%	Oper. Margin	23.83%	RSI (14)	43.71	Volatility	2.02% 1.80%
Employees	138100	Debt/Eq	0.67	Sales Y/Y TTM	-0.37%	Profit Margin	24.41%	Recom	2.20	Target Price	170.84
Option/Short	Yes / Yes	LT Debt/Eq	0.49	EPS Q/Q	238.80%	Payout	84.80%	Rel Volume	0.88	Prev Close	149.61
Sales Surprise	1.55%	EPS Surprise	7.33%	Sales Q/Q	2.39%	Earnings	Apr 15 BMO	Avg Volume	9.72M	Price	151.02
SMA20	-2.06%	SMA50	-3.95%	SMA200	-3.76%	Trades		Volume	1,661,636	Change	0.94%

Date	Action	Analyst	Rating Change	Price Target Change
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$153
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183

Show Previous Ratings

Today 09:40AM	Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock (Zacks)
May-15-25 05:48PM	Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails (Business Wire)
11:30AM	Why Is Johnson & Johnson (JNJ) Down 4.9% Since Last Earnings Report? (Zacks)
06:49AM	ISRG Stock Gains More than 8% YTD: Will the Uptrend Continue? (Zacks)
May-14-25 04:40PM	Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (Business Wire)
11:00AM	Loading…
11:00AM	Halozyme, J&J slide as analyst cuts rating on CMS draft guidance (TipRanks)
May-13-25 09:41PM	The Smartest Dividend Stocks to Buy With $5,000 Right Now (Motley Fool)
05:08PM	Is Johnson & Johnson (JNJ) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? (Insider Monkey)
04:53PM	Big Pharma Counted on This Loophole. It May Be Closing. (Barrons.com)
04:18PM	Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News (Investor's Business Daily)
02:47PM	Big Pharma Counted on a Price Negotiation Loophole. It May Be Closing. (Barrons.com)
09:56AM	Bayer Q1 Earnings Beat Estimates, Crop Science Unit Hurts Sales (Zacks)
09:22AM	The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen (Zacks)
08:21AM	RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US (Zacks)
04:00AM	With the breakneck speed of cancer breakthroughs, oncologists feel left behind. Can Big Pharma chime in? (Pharma Voice)
04:55PM	Loading…
May-12-25 04:55PM	Analyst Report: Johnson & Johnson (Morningstar Research)
04:25PM	S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite' (Investor's Business Daily)
12:42PM	HistoSonics secures first insurance coverage for histotripsy system (Medical Device Network)
10:44AM	Trump expected to sign order to slash US drug prices (Yahoo Finance Video)
10:01AM	Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers (Yahoo Finance Video)
10:00AM	S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Outlines Drug-Price Reform (Investor's Business Daily)
09:37AM	Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs (Zacks)
09:09AM	US-China trade truce, April CPI, drug prices: 3 Things (Yahoo Finance Video)
08:11AM	J&J Oral Psoriasis Drug Meets Primary Goal in Late-Stage Study (Zacks)
06:20AM	Is Invesco S&P 500 Quality ETF (SPHQ) a Strong ETF Right Now? (Zacks)
05:20AM	J&J reports new data from Phase III trial of icotrokinra for plaque psoriasis (Clinical Trials Arena)
May-10-25 04:09AM	Is Johnson & Johnson (JNJ) the Best Income Stock to Invest in Now? (Insider Monkey)
May-09-25 08:05AM	Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis (PR Newswire)
06:33AM	Is Johnson & Johnson (JNJ) the Best Medical Device Stock to Buy Now? (Insider Monkey)
03:45AM	Zymeworks Inc (ZYME) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
05:58PM	Loading…
May-08-25 05:58PM	From Apple to GM, Tariffs to Cost Companies Tens of Billions (Bloomberg)
11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
08:22AM	Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Sales Outlook (Investopedia)
08:22AM	Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Net Sales Outlook (Investopedia)
08:12AM	Johnson & Johnson expands efforts to champion the nursing workforce globally (Business Wire)
07:48AM	TEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up (Zacks)
12:45AM	Dividend Hikes Offer Optimism Amid Tariff Turmoil (Seeking Alpha)
May-07-25 04:56PM	Hartford Balanced Income Fund Q1 2025 Commentary (Seeking Alpha)
04:51PM	Trump planning on Executive Order to further cut Medicare drug prices - report (Seeking Alpha)
03:14PM	Gilead to invest about $32B in U.S. manufacturing through 2030 (Seeking Alpha)
02:54PM	FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight (Benzinga)
02:28PM	Is Johnson & Johnson (JNJ) the Best Dow Stock? (Insider Monkey)
12:49PM	J&J Medtech survey finds strong European support for healthcare data sharing (Medical Device Network)
12:13PM	HALO Stock Up on Q1 Earnings and Revenue Beat, Raised 2025 View (Zacks)
11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
10:32AM	Pfizer, J&J, Genentech drugs subject of FDA advisory panel meeting this month (Seeking Alpha)
08:48AM	The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie (Zacks)
06:20AM	Should WisdomTree U.S. Total Dividend ETF (DTD) Be on Your Investing Radar? (Zacks)
05:30AM	Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better. (The Wall Street Journal)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-06-25 09:10AM	The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific (Zacks)
09:00AM	Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock (Zacks)
08:26AM	JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects? (Zacks)
06:20AM	Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? (Zacks)
05:12AM	ChatGPT Stock Advice: Johnson & Johnson (JNJ) Among Top Stock Recommendations (Insider Monkey)
May-05-25 03:00PM	MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know (Zacks)
09:29AM	Was Jim Cramer Right About Johnson & Johnson (JNJ)? (Insider Monkey)
08:05AM	TREMFYA (guselkumab) positioned to become the first and only IL-23 inhibitor to offer subcutaneous induction in ulcerative colitis as demonstrated in new data through 24 weeks (PR Newswire)
08:05AM	TREMFYA (guselkumab) delivers sustained clinical and endoscopic remission in ulcerative colitis through two years (PR Newswire)
08:01AM	AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth (Zacks)
07:42AM	Franklin Income SMA Q1 2025 Commentary (Seeking Alpha)
07:30AM	Fidelity Contrafund Q1 2025 Commentary (Seeking Alpha)
12:38AM	Franklin Equity Income SMA Q1 2025 Commentary (Seeking Alpha)
May-04-25 11:16PM	If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
11:19AM	Is Johnson & Johnson (JNJ) The Most Profitable Cheap Stock to Buy Now? (Insider Monkey)
06:35AM	Franklin Small Cap Growth SMA Q1 2025 Commentary (Seeking Alpha)
04:49AM	Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? (Motley Fool)
May-03-25 09:46AM	Dogs Of The Dow Chase May's 'Safer' Buy (Seeking Alpha)
04:51AM	The Play On Legend Biotech (Seeking Alpha)
May-02-25 02:15PM	Calls of the Day: AutoZone, Roblox, Eli Lilly, Johnson & Johnson and Quanta Services (CNBC TV)
11:06AM	Q1 earnings pulse check: companies tentative on pharma-specific tariffs (Pharmaceutical Technology)
07:50AM	Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth (Zacks)
07:25AM	Tweedy, Browne Fund Q1 2025 Commentary (Seeking Alpha)
May-01-25 12:06PM	'Declare victory and move on': Eli Lilly CEO on Trump tariff threat (Yahoo Finance)
11:45AM	ClearBridge Value Fund Q1 2025 Commentary (Seeking Alpha)
11:35AM	ClearBridge Small Cap Growth Fund Q1 2025 Commentary (Seeking Alpha)
08:24AM	Pharma downplays tariff threat, even as risks remain unclear (BioPharma Dive)
08:00AM	If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors Again? (Investor's Business Daily)
06:40AM	FDA approves J&Js Imaavy for generalised myasthenia gravis (Pharmaceutical Technology)
06:20AM	Is WisdomTree U.S. Total Dividend ETF (DTD) a Strong ETF Right Now? (Zacks)
04:49AM	The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis (Zacks)
01:40AM	Franklin Income Fund Q1 2025 Commentary (Seeking Alpha)
Apr-30-25 11:32PM	Tracking AMG's Yacktman Asset Management Portfolio - Q1 2025 Update (Seeking Alpha)
09:48PM	Trump Says Tariffs Politically Risky, But Hes Not Rushing Deals (Bloomberg)
05:02PM	Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems (Zacks)
04:17PM	Johnson & Johnson (JNJ): Jim Cramer Says "They Love the Weak Dollar" - Is This Quiet Giant Back in Favor? (Insider Monkey)
02:28PM	Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months? (Insider Monkey)
11:45AM	GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance (Zacks)
10:30AM	The Davenport Value & Income Fund Q1 2025 Commentary (Seeking Alpha)
08:29AM	Johnson & Johnson receives FDA approval for IMAAVY (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG) (PR Newswire)
07:51AM	J&J secures FDA OK for immune drug touted as future blockbuster (BioPharma Dive)
Apr-29-25 08:32PM	Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations? (Zacks)
08:07PM	Best Dividend Aristocrats For May 2025 (Seeking Alpha)
03:46PM	SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO (Seeking Alpha)
11:34AM	Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales (Zacks)
11:10AM	4 PFA studies in the spotlight at Heart Rhythm 2025 (MedTech Dive)
08:33AM	Johnson & Johnson (JNJ): Among the Best Long-Term Dividend Stocks to Buy According to Billionaires (Insider Monkey)
06:20AM	Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? (Zacks)
06:20AM	Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar? (Zacks)
Apr-28-25 06:25PM	Stocks Rise in Final Hour of Wall Street Trading: Markets Wrap (Bloomberg)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '25	Option Exercise	0.00	25,255	0	40,797	May 05 05:10 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Option Exercise	101.87	6,999	712,988	28,000	Feb 26 06:42 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Sale	165.88	6,999	1,160,994	21,001	Feb 26 06:42 PM
Decker Robert J	Officer	Feb 25 '25	Proposed Sale	165.88	6,999	1,161,010		Feb 25 03:05 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	2,806	0	17,904	Feb 18 09:46 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '25	Option Exercise	0.00	1,029	0	15,501	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	1,765	0	15,111	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '25	Option Exercise	0.00	499	0	13,539	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '25	Sale	156.15	403	62,928	15,098	Feb 18 09:33 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '25	Option Exercise	0.00	607	0	91,037	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 14 '25	Option Exercise	0.00	7,367	0	96,674	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '25	Option Exercise	0.00	651	0	89,603	Feb 18 09:16 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '25	Option Exercise	0.00	1,971	0	6,113	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 14 '25	Option Exercise	0.00	19,330	0	20,661	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '25	Option Exercise	0.00	1,779	0	1,779	Feb 18 09:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '25	Option Exercise	0.00	1,350	0	15,927	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '25	Option Exercise	0.00	1,594	0	171,110	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 14 '25	Option Exercise	0.00	19,518	0	185,924	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '25	Option Exercise	0.00	1,302	0	167,221	Feb 18 09:08 PM
Swanson James D.	EVP, CIO	Feb 15 '25	Option Exercise	0.00	492	0	16,762	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 14 '25	Option Exercise	0.00	5,079	0	19,739	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 13 '25	Option Exercise	0.00	447	0	15,019	Feb 18 09:06 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '25	Option Exercise	0.00	419	0	13,095	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	2,608	0	14,576	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '25	Option Exercise	0.00	411	0	12,100	Feb 18 09:05 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 15 '25	Option Exercise	0.00	961	0	10,321	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 14 '25	Option Exercise	0.00	2,203	0	11,366	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '25	Option Exercise	0.00	651	0	8,991	Feb 18 09:03 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '25	Option Exercise	0.00	3,682	0	397,525	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 14 '25	Option Exercise	0.00	24,335	0	415,205	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '25	Option Exercise	0.00	3,470	0	392,498	Feb 18 09:02 PM
Decker Robert J	VP Corporate Controller	Feb 15 '25	Option Exercise	0.00	339	0	20,116	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 14 '25	Option Exercise	0.00	2,201	0	21,373	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 13 '25	Option Exercise	0.00	312	0	19,285	Feb 18 09:01 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '25	Option Exercise	0.00	492	0	21,839	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 14 '25	Option Exercise	0.00	4,740	0	24,591	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '25	Option Exercise	0.00	408	0	20,242	Feb 18 08:58 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 07 '25	Option Exercise	100.06	126,369	12,644,482	489,671	Feb 11 07:43 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 07 '25	Option Exercise	100.06	32,762	3,278,166	115,028	Feb 11 07:42 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 07 '25	Option Exercise	100.06	58,504	5,853,910	213,355	Feb 11 07:41 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Option Exercise	100.06	13,015	1,302,281	13,015	Feb 11 07:40 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Sale	153.89	13,015	2,002,878	0	Feb 11 07:40 PM
Wolk Joseph J	Officer	Feb 07 '25	Proposed Sale	153.89	13,015	2,002,924		Feb 07 01:27 PM
WEINBERGER MARK A	Director	Dec 12 '24	Buy	147.22	1,000	147,220	1,000	Dec 12 05:27 PM
Hait William	Former Officer	Dec 04 '24	Proposed Sale	149.90	25,742	3,858,598		Dec 04 01:25 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Option Exercise	100.06	5,635	563,838	24,608	Sep 03 04:48 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Sale	165.06	5,635	930,113	18,973	Sep 03 04:48 PM
Decker Robert J	Officer	Aug 30 '24	Proposed Sale	165.06	5,635	930,113		Aug 30 03:51 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 08 '24	Option Exercise	0.00	9,809	0	24,852	Jul 09 05:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience